|1.||Tarasov, S A: 6 articles (10/2010 - 01/2008)|
|2.||Sergeeva, S A: 5 articles (10/2010 - 01/2008)|
|3.||Kachanova, M V: 5 articles (09/2009 - 01/2008)|
|4.||Osidak, L V: 3 articles (08/2009 - 08/2009)|
|5.||Zhavbert, E S: 2 articles (01/2013 - 08/2009)|
|6.||Dugina, Iu L: 2 articles (01/2013 - 01/2008)|
|7.||Skarnovich, M O: 2 articles (10/2010 - 12/2008)|
|8.||Epstein, O I: 2 articles (10/2010 - 12/2008)|
|9.||Sergeev, A A: 2 articles (10/2010 - 12/2008)|
|10.||Kabanov, A S: 2 articles (10/2010 - 12/2008)|
01/01/2008 - "The high efficacy of anaferon and no adverse effects allowed to consider it as the drug of choice in the treatment of various viral infections including those in children under 1 year."
10/01/2010 - "Anaferon (pediatric formulation) administered in the therapeutic-and-prophylactic regimen to mice receiving intranasally 100% infecting dose of A/California/07/2009(H1N1)v influenza virus exhibited an antiviral effect and 10-fold reduced the production of influenza virus in the lungs of infected mice on days 4, 6, and 8 after infection compared to the control (distilled water). "
08/01/2009 - "Therapeutic efficiency and safety of anaferon (pediatric formuation) as a component of complex therapy of acute respiratory viral infections with involvement of the gastrointestinal tract were proven; more rapid disappearance of all symptoms and improvement of the immune status parameters were demonstrated."
08/01/2009 - "Anaferon (pediatric formulation) in prophylactics of acute respiratory viral infection in children."
08/01/2009 - "The use of anaferon (pediatric formulation) for prophylaxis of acute respiratory viral infections in preschool children."
|2.||Human Influenza (Influenza)
03/01/2013 - "An important role in the prevention and treatment of influenza and ARVI occupy modern nanotechnological products of natural origin such as anaferon, aflubin, oscillococcinum having antiviral, immunomodulatory, anti-inflammatory, disintoxicational and antipyretic activity."
12/01/2008 - "Study of efficiency of therapeutic and preventive anaferon (pediatric formulation) in mice with influenza infection."
|3.||Bacterial Infections (Bacterial Infection)
08/01/2009 - "Comparative placebo-controlled clinical trials on the efficiency and safety of ultralow doses of antibodies to human IFN-gamma (anaferon pediatric formulation and anaferon) and prophylaxis of bacterial complication showed that administration of these preparations in complex therapy of bacterial infection reduced the incidence of bacterial complications of viral infections and considerably decreased the duration of the main clinical symptoms of the disease."
|4.||Respiratory Tract Infections (Respiratory Tract Infection)
08/01/2009 - "The efficiency of IFN inductor anaferon (pediatric formulation) and the possibility of its application in the therapy of children with acute respiratory infections were demonstrated."
08/01/2009 - "Efficiency of interferon inductor anaferon (pediatric formulation) in prophylaxis of acute respiratory infections in sickly children."
|5.||Herpes Genitalis (Genital Herpes)
08/01/2009 - "Anaferon-supplemented complex therapy of chronic recurrent genital herpes reduced clinical symptoms of the disease and normalized the content of immunocompetent cells. "
08/01/2009 - "We studied clinical efficiency and IFN-inducing activity of anaferon in chronic recurrent genital herpes with high incidence of relapses. "
08/01/2009 - "Efficiency of anaferon in complex therapy of genital herpes."
|2.||Interferon-gamma (Interferon, gamma)
|3.||RNA (Ribonucleic Acid)
|4.||DNA (Deoxyribonucleic Acid)